Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13181
-
13182
-
13183
-
13184
-
13185
Supplementary Material for: Vitamin D status and treatment in ESKD; links to improved CKD-MBD laboratory parameters in a real-world setting
Published 2024“…Laboratory parameters were measured every 6 (phosphate, calcium) or 12 weeks (25(OH)D3, PTH, ALP) until February, 2021. In September, 2018 a treatment algorithm of 50,000 IU weekly until sufficient, followed by 50,000 IU monthly was suggested. …”
-
13186
Self-paced combined training alleviated oxidative stress, inflammatory responses and hyperlipidaemia in people living with multiple sclerosis: a randomised controlled trial
Published 2024“…</p> <p><b>Results:</b> Comparatively with CG, the TG showed a decrease in advanced oxidation protein products (p = 0.002, Hedges’g (g) = 1.50) and total thiols (p = 0.0011, g = 1.57), as well as an increase in reduced glutathione (p = 0.03, g = 0.98). …”
-
13187
Items.
Published 2023“…<div><p>Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). …”
-
13188
Survey feedback.
Published 2023“…<div><p>Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). …”
-
13189
DataSheet_1_A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor ac...
Published 2023“…Background<p>QL1604 is a humanized immunoglobulin G4 monoclonal antibody against programmed cell death protein 1. …”
-
13190
Variation law of UCS.
Published 2025“…Notably, the attenuation constant λ follows a monotonically decreasing pattern with increasing loading rate. …”
-
13191
-
13192
-
13193
-
13194
-
13195
-
13196
-
13197
-
13198
-
13199
-
13200